Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 118.78B | -240.1x | 2.04 | EUR 463.25 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regeneron Pharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 73.47B | 18.1x | 1.67 | EUR 645.60 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
argenx | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 32.24B | 41.2x | 0.13 | EUR 549.60 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biontech | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 23.48B | -50.2x | 0.44 | EUR 96.55 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioNTech SE | Xetra | Healthcare | Biotechnology & Medical Research | EUR 23.45B | -50.5x | 0.44 | EUR 98.05 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moderna | Xetra | Healthcare | Biotechnology & Medical Research | EUR 13.19B | -4x | -0.16 | EUR 34.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moderna | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 12.86B | -3.9x | -0.16 | EUR 34 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Exelixis | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 10.31B | 22x | 0.12 | EUR 36.54 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascendis Pharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 8.06B | -22.1x | -0.9 | EUR 130 | -6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qiagen NV | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 7.90B | 106.7x | -1.34 | EUR 36.10 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.9% Upside | Upgrade to Pro+ | |
Qiagen | Xetra | Healthcare | Biotechnology & Medical Research | EUR 7.90B | 106.7x | -1.34 | EUR 36.53 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.2% Upside | Upgrade to Pro+ | |
Blueprint Medicines | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 5.16B | -80.7x | -0.95 | EUR 80.74 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ionis Pharmaceuticals | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 4.76B | -13.1x | 0.63 | EUR 30.80 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merus NV | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 2.96B | -13.7x | 1.27 | EUR 39.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhythm Pharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 2.87B | -11.2x | 0.34 | EUR 44.60 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Denali Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 2.06B | -5.9x | 0.04 | EUR 15.25 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 2.05B | 25.8x | 0.19 | EUR 37.55 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Xetra | Healthcare | Biotechnology & Medical Research | EUR 2.05B | 25.8x | 0.19 | EUR 37.30 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genus | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 1.49B | -311.5x | 2.81 | EUR 22.60 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novavax | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 1.24B | -6.7x | -0.1 | EUR 7.60 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viridian Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 1.18B | -5x | -0.29 | EUR 14.80 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evotec | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 1.13B | -6.6x | 0.09 | EUR 6.49 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evotec AG | Xetra | Healthcare | Biotechnology & Medical Research | EUR 1.13B | -6.6x | 0.09 | EUR 6.38 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Iovance Biotherapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 1.13B | -2.9x | -0.1 | EUR 3.41 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Syndax Pharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 1.02B | -3.4x | 0.15 | EUR 12.10 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareDx | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 948.47M | 18.3x | 0.16 | EUR 17.24 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellia Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 927.81M | -1.8x | -0.66 | EUR 8.91 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GNI | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 719.99M | 117.2x | -1.42 | EUR 13.90 | -17.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takara Bio | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 631.99M | -1,940x | 18.6 | EUR 5 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Xetra | Healthcare | Biotechnology & Medical Research | EUR 621.39M | -2.2x | -0.14 | EUR 2.78 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curevac | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 614.54M | -2.2x | -0.14 | EUR 2.70 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arbutus Biopharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 548.91M | -7.3x | -1.01 | EUR 2.98 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Savara | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 519.66M | -6.2x | 0.2 | EUR 2.36 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Formycon | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 444.95M | 6.5x | 0.03 | EUR 25 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Formycon | Xetra | Healthcare | Biotechnology & Medical Research | EUR 444.95M | 6.5x | 0.03 | EUR 25.15 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 387.20M | -2x | -1.49 | EUR 6.80 | -9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Altimmune | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 385.69M | -4x | -0.23 | EUR 5.06 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aldeyra Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 363.58M | -6.9x | 0.14 | EUR 5.83 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Verastem | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 301.28M | -2.3x | -0.16 | EUR 6.40 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
aTyr Pharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 244.71M | -3.4x | -6.25 | EUR 3.06 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ironwood Pharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 212.93M | 143x | 1.32 | EUR 1.34 | -8.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amarin | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 201.20M | -6.2x | -0.25 | EUR 0.43 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ProQR Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 175.94M | -5.7x | -0.22 | EUR 1.90 | 8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Larimar Therapeutics Inc | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 171.57M | -2.5x | 0.06 | EUR 2.72 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tiziana Life Sciences | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 170.12M | -7.6x | -0.46 | EUR 1.53 | 11.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 142.21M | -3.9x | -0.08 | EUR 2.94 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hansa Biopharma | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 140.76M | -1.8x | -0.1 | EUR 2.08 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 121.86M | -0.5x | 0 | EUR 0.35 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Heidelberg Pharma AG | Xetra | Healthcare | Biotechnology & Medical Research | EUR 121.17M | -6.4x | -0.44 | EUR 2.60 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Heidelberg Pharma AG | Frankfurt | Healthcare | Biotechnology & Medical Research | EUR 121.17M | -6.4x | -0.44 | EUR 2.54 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |